nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—Hepatic cirrhosis—Furosemide—dilated cardiomyopathy	0.0433	0.0524	CcSEcCtD
Tizanidine—Clonidine—SLC22A5—dilated cardiomyopathy	0.0176	1	CrCbGaD
Tizanidine—Pyelonephritis—Lisinopril—dilated cardiomyopathy	0.0164	0.0198	CcSEcCtD
Tizanidine—Bursitis—Lisinopril—dilated cardiomyopathy	0.0129	0.0156	CcSEcCtD
Tizanidine—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.012	0.0145	CcSEcCtD
Tizanidine—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.0103	0.0125	CcSEcCtD
Tizanidine—Glycosuria—Furosemide—dilated cardiomyopathy	0.0102	0.0124	CcSEcCtD
Tizanidine—ADRA2B—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00938	0.0601	CbGpPWpGaD
Tizanidine—ADRA2C—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00877	0.0562	CbGpPWpGaD
Tizanidine—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00864	0.0104	CcSEcCtD
Tizanidine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00853	0.0103	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00846	0.0102	CcSEcCtD
Tizanidine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00838	0.0101	CcSEcCtD
Tizanidine—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00827	0.01	CcSEcCtD
Tizanidine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00813	0.00984	CcSEcCtD
Tizanidine—Otitis media—Lisinopril—dilated cardiomyopathy	0.008	0.00967	CcSEcCtD
Tizanidine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00796	0.00963	CcSEcCtD
Tizanidine—ADRA2B—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.0076	0.0487	CbGpPWpGaD
Tizanidine—Bladder pain—Furosemide—dilated cardiomyopathy	0.0075	0.00908	CcSEcCtD
Tizanidine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00724	0.00876	CcSEcCtD
Tizanidine—Mental disability—Furosemide—dilated cardiomyopathy	0.0072	0.00871	CcSEcCtD
Tizanidine—ADRA2A—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00712	0.0456	CbGpPWpGaD
Tizanidine—ADRA2C—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.0071	0.0455	CbGpPWpGaD
Tizanidine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00689	0.00834	CcSEcCtD
Tizanidine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00677	0.00819	CcSEcCtD
Tizanidine—Deafness—Furosemide—dilated cardiomyopathy	0.00673	0.00815	CcSEcCtD
Tizanidine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00673	0.00815	CcSEcCtD
Tizanidine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00662	0.00801	CcSEcCtD
Tizanidine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00641	0.00776	CcSEcCtD
Tizanidine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00638	0.00772	CcSEcCtD
Tizanidine—Neck pain—Lisinopril—dilated cardiomyopathy	0.0063	0.00762	CcSEcCtD
Tizanidine—Purpura—Furosemide—dilated cardiomyopathy	0.00625	0.00756	CcSEcCtD
Tizanidine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00622	0.00753	CcSEcCtD
Tizanidine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00622	0.00753	CcSEcCtD
Tizanidine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00618	0.00748	CcSEcCtD
Tizanidine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00608	0.00736	CcSEcCtD
Tizanidine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00605	0.00732	CcSEcCtD
Tizanidine—Malaise—Spironolactone—dilated cardiomyopathy	0.00601	0.00727	CcSEcCtD
Tizanidine—Cystitis—Lisinopril—dilated cardiomyopathy	0.00601	0.00727	CcSEcCtD
Tizanidine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00597	0.00722	CcSEcCtD
Tizanidine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00584	0.00707	CcSEcCtD
Tizanidine—ADRA2A—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00577	0.037	CbGpPWpGaD
Tizanidine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00573	0.00693	CcSEcCtD
Tizanidine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00563	0.00681	CcSEcCtD
Tizanidine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00561	0.00678	CcSEcCtD
Tizanidine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00554	0.0067	CcSEcCtD
Tizanidine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.0055	0.00666	CcSEcCtD
Tizanidine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00549	0.00664	CcSEcCtD
Tizanidine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00548	0.00663	CcSEcCtD
Tizanidine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00546	0.0066	CcSEcCtD
Tizanidine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00544	0.00658	CcSEcCtD
Tizanidine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00533	0.00645	CcSEcCtD
Tizanidine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00531	0.00643	CcSEcCtD
Tizanidine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00517	0.00626	CcSEcCtD
Tizanidine—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.0051	0.00617	CcSEcCtD
Tizanidine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00503	0.00608	CcSEcCtD
Tizanidine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00489	0.00592	CcSEcCtD
Tizanidine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00484	0.00585	CcSEcCtD
Tizanidine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00481	0.00582	CcSEcCtD
Tizanidine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.0047	0.00568	CcSEcCtD
Tizanidine—Arthritis—Lisinopril—dilated cardiomyopathy	0.00465	0.00563	CcSEcCtD
Tizanidine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00464	0.00562	CcSEcCtD
Tizanidine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00461	0.00558	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.0046	0.00557	CcSEcCtD
Tizanidine—Renal failure—Furosemide—dilated cardiomyopathy	0.00456	0.00552	CcSEcCtD
Tizanidine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00454	0.00549	CcSEcCtD
Tizanidine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00448	0.00542	CcSEcCtD
Tizanidine—Sweating—Furosemide—dilated cardiomyopathy	0.00445	0.00538	CcSEcCtD
Tizanidine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00439	0.00531	CcSEcCtD
Tizanidine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00433	0.00524	CcSEcCtD
Tizanidine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00432	0.00523	CcSEcCtD
Tizanidine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0043	0.0052	CcSEcCtD
Tizanidine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.0043	0.0052	CcSEcCtD
Tizanidine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00413	0.00499	CcSEcCtD
Tizanidine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00411	0.00498	CcSEcCtD
Tizanidine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00408	0.00494	CcSEcCtD
Tizanidine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00401	0.00485	CcSEcCtD
Tizanidine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00394	0.00477	CcSEcCtD
Tizanidine—Asthma—Lisinopril—dilated cardiomyopathy	0.00391	0.00473	CcSEcCtD
Tizanidine—Influenza—Lisinopril—dilated cardiomyopathy	0.00391	0.00473	CcSEcCtD
Tizanidine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00388	0.0047	CcSEcCtD
Tizanidine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00385	0.00466	CcSEcCtD
Tizanidine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.0038	0.0046	CcSEcCtD
Tizanidine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00378	0.00457	CcSEcCtD
Tizanidine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00376	0.00455	CcSEcCtD
Tizanidine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00376	0.00454	CcSEcCtD
Tizanidine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00372	0.0045	CcSEcCtD
Tizanidine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00372	0.0045	CcSEcCtD
Tizanidine—Dizziness—Spironolactone—dilated cardiomyopathy	0.0036	0.00435	CcSEcCtD
Tizanidine—Flatulence—Furosemide—dilated cardiomyopathy	0.00357	0.00432	CcSEcCtD
Tizanidine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00353	0.00428	CcSEcCtD
Tizanidine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00352	0.00426	CcSEcCtD
Tizanidine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.0035	0.00424	CcSEcCtD
Tizanidine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00349	0.00422	CcSEcCtD
Tizanidine—Depression—Lisinopril—dilated cardiomyopathy	0.00347	0.0042	CcSEcCtD
Tizanidine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00346	0.00419	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00345	0.00418	CcSEcCtD
Tizanidine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00343	0.00415	CcSEcCtD
Tizanidine—Rash—Spironolactone—dilated cardiomyopathy	0.00343	0.00415	CcSEcCtD
Tizanidine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00343	0.00415	CcSEcCtD
Tizanidine—Renal failure—Lisinopril—dilated cardiomyopathy	0.00342	0.00414	CcSEcCtD
Tizanidine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00342	0.00414	CcSEcCtD
Tizanidine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00341	0.00413	CcSEcCtD
Tizanidine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00341	0.00413	CcSEcCtD
Tizanidine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00339	0.00411	CcSEcCtD
Tizanidine—Anaemia—Furosemide—dilated cardiomyopathy	0.00335	0.00406	CcSEcCtD
Tizanidine—Sweating—Lisinopril—dilated cardiomyopathy	0.00334	0.00404	CcSEcCtD
Tizanidine—Agitation—Furosemide—dilated cardiomyopathy	0.00333	0.00403	CcSEcCtD
Tizanidine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00332	0.00402	CcSEcCtD
Tizanidine—ADRA2B—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00332	0.0213	CbGpPWpGaD
Tizanidine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00329	0.00398	CcSEcCtD
Tizanidine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00327	0.00395	CcSEcCtD
Tizanidine—Vertigo—Furosemide—dilated cardiomyopathy	0.00326	0.00394	CcSEcCtD
Tizanidine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00325	0.00393	CcSEcCtD
Tizanidine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00325	0.00393	CcSEcCtD
Tizanidine—Nausea—Spironolactone—dilated cardiomyopathy	0.00323	0.00391	CcSEcCtD
Tizanidine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00318	0.00385	CcSEcCtD
Tizanidine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00313	0.00379	CcSEcCtD
Tizanidine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00313	0.00378	CcSEcCtD
Tizanidine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00311	0.00376	CcSEcCtD
Tizanidine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.0031	0.00375	CcSEcCtD
Tizanidine—ADRA2C—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0031	0.0199	CbGpPWpGaD
Tizanidine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00309	0.00374	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00307	0.00371	CcSEcCtD
Tizanidine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00306	0.00371	CcSEcCtD
Tizanidine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00302	0.00365	CcSEcCtD
Tizanidine—Confusional state—Furosemide—dilated cardiomyopathy	0.00298	0.00361	CcSEcCtD
Tizanidine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00296	0.00358	CcSEcCtD
Tizanidine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00296	0.00358	CcSEcCtD
Tizanidine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00291	0.00353	CcSEcCtD
Tizanidine—Shock—Furosemide—dilated cardiomyopathy	0.00291	0.00352	CcSEcCtD
Tizanidine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.0029	0.00351	CcSEcCtD
Tizanidine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.0029	0.00351	CcSEcCtD
Tizanidine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00287	0.00348	CcSEcCtD
Tizanidine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00286	0.00346	CcSEcCtD
Tizanidine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00284	0.00343	CcSEcCtD
Tizanidine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00282	0.00341	CcSEcCtD
Tizanidine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00279	0.00338	CcSEcCtD
Tizanidine—ADRA2B—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00279	0.0179	CbGpPWpGaD
Tizanidine—Hypotension—Furosemide—dilated cardiomyopathy	0.00277	0.00335	CcSEcCtD
Tizanidine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00276	0.00334	CcSEcCtD
Tizanidine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00274	0.00331	CcSEcCtD
Tizanidine—ADRA2B—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00269	0.0172	CbGpPWpGaD
Tizanidine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00268	0.00324	CcSEcCtD
Tizanidine—Tension—Lisinopril—dilated cardiomyopathy	0.00267	0.00323	CcSEcCtD
Tizanidine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00266	0.00322	CcSEcCtD
Tizanidine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00264	0.0032	CcSEcCtD
Tizanidine—Back pain—Lisinopril—dilated cardiomyopathy	0.00263	0.00319	CcSEcCtD
Tizanidine—Somnolence—Furosemide—dilated cardiomyopathy	0.00263	0.00318	CcSEcCtD
Tizanidine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00262	0.00317	CcSEcCtD
Tizanidine—ADRA2C—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00261	0.0167	CbGpPWpGaD
Tizanidine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00256	0.0031	CcSEcCtD
Tizanidine—Fatigue—Furosemide—dilated cardiomyopathy	0.00255	0.00309	CcSEcCtD
Tizanidine—Tremor—Lisinopril—dilated cardiomyopathy	0.00255	0.00308	CcSEcCtD
Tizanidine—Constipation—Furosemide—dilated cardiomyopathy	0.00253	0.00306	CcSEcCtD
Tizanidine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00252	0.00306	CcSEcCtD
Tizanidine—ADRA2A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00252	0.0161	CbGpPWpGaD
Tizanidine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00251	0.00304	CcSEcCtD
Tizanidine—ADRA2C—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00251	0.0161	CbGpPWpGaD
Tizanidine—Malaise—Lisinopril—dilated cardiomyopathy	0.00245	0.00297	CcSEcCtD
Tizanidine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00244	0.00296	CcSEcCtD
Tizanidine—Syncope—Lisinopril—dilated cardiomyopathy	0.00244	0.00295	CcSEcCtD
Tizanidine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00244	0.00295	CcSEcCtD
Tizanidine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00244	0.00295	CcSEcCtD
Tizanidine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00242	0.00293	CcSEcCtD
Tizanidine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00239	0.00289	CcSEcCtD
Tizanidine—Urticaria—Furosemide—dilated cardiomyopathy	0.00235	0.00285	CcSEcCtD
Tizanidine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00234	0.00283	CcSEcCtD
Tizanidine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00234	0.00283	CcSEcCtD
Tizanidine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00232	0.0028	CcSEcCtD
Tizanidine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00231	0.00279	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.0023	0.00278	CcSEcCtD
Tizanidine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00229	0.00277	CcSEcCtD
Tizanidine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00227	0.00274	CcSEcCtD
Tizanidine—ADRA2B—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00226	0.0145	CbGpPWpGaD
Tizanidine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00224	0.00271	CcSEcCtD
Tizanidine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00222	0.00269	CcSEcCtD
Tizanidine—Oedema—Lisinopril—dilated cardiomyopathy	0.00222	0.00269	CcSEcCtD
Tizanidine—Infection—Lisinopril—dilated cardiomyopathy	0.00221	0.00267	CcSEcCtD
Tizanidine—Shock—Lisinopril—dilated cardiomyopathy	0.00218	0.00264	CcSEcCtD
Tizanidine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00218	0.00264	CcSEcCtD
Tizanidine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00217	0.00263	CcSEcCtD
Tizanidine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00217	0.00262	CcSEcCtD
Tizanidine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00216	0.00261	CcSEcCtD
Tizanidine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00215	0.0026	CcSEcCtD
Tizanidine—Asthenia—Furosemide—dilated cardiomyopathy	0.00212	0.00257	CcSEcCtD
Tizanidine—ADRA2A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00212	0.0136	CbGpPWpGaD
Tizanidine—ADRA2C—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00211	0.0135	CbGpPWpGaD
Tizanidine—Pruritus—Furosemide—dilated cardiomyopathy	0.00209	0.00253	CcSEcCtD
Tizanidine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00208	0.00251	CcSEcCtD
Tizanidine—ADRA2A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00204	0.0131	CbGpPWpGaD
Tizanidine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00203	0.00245	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00202	0.00245	CcSEcCtD
Tizanidine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00199	0.00241	CcSEcCtD
Tizanidine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00198	0.0024	CcSEcCtD
Tizanidine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00197	0.00239	CcSEcCtD
Tizanidine—Dizziness—Furosemide—dilated cardiomyopathy	0.00196	0.00237	CcSEcCtD
Tizanidine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00195	0.00237	CcSEcCtD
Tizanidine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00191	0.00232	CcSEcCtD
Tizanidine—Constipation—Lisinopril—dilated cardiomyopathy	0.0019	0.0023	CcSEcCtD
Tizanidine—Vomiting—Furosemide—dilated cardiomyopathy	0.00188	0.00228	CcSEcCtD
Tizanidine—Rash—Furosemide—dilated cardiomyopathy	0.00187	0.00226	CcSEcCtD
Tizanidine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00186	0.00226	CcSEcCtD
Tizanidine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00183	0.00221	CcSEcCtD
Tizanidine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00182	0.0022	CcSEcCtD
Tizanidine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00176	0.00213	CcSEcCtD
Tizanidine—Nausea—Furosemide—dilated cardiomyopathy	0.00176	0.00213	CcSEcCtD
Tizanidine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00176	0.00212	CcSEcCtD
Tizanidine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00176	0.00212	CcSEcCtD
Tizanidine—ADRA2A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00171	0.011	CbGpPWpGaD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00169	0.0109	CbGpPWpGaD
Tizanidine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00164	0.00198	CcSEcCtD
Tizanidine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00159	0.00193	CcSEcCtD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00158	0.0101	CbGpPWpGaD
Tizanidine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00157	0.0019	CcSEcCtD
Tizanidine—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00154	0.00988	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00153	0.00982	CbGpPWpGaD
Tizanidine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00152	0.00184	CcSEcCtD
Tizanidine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00147	0.00178	CcSEcCtD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00143	0.00918	CbGpPWpGaD
Tizanidine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00141	0.00171	CcSEcCtD
Tizanidine—Rash—Lisinopril—dilated cardiomyopathy	0.0014	0.00169	CcSEcCtD
Tizanidine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0014	0.00169	CcSEcCtD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00133	0.00852	CbGpPWpGaD
Tizanidine—Nausea—Lisinopril—dilated cardiomyopathy	0.00132	0.0016	CcSEcCtD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00129	0.00824	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00124	0.00796	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00116	0.00745	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00113	0.00724	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00106	0.00676	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00101	0.00646	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000857	0.00549	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TTN—dilated cardiomyopathy	0.00079	0.00506	CbGpPWpGaD
Tizanidine—ADRA2B—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000766	0.00491	CbGpPWpGaD
Tizanidine—ADRA2B—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000766	0.00491	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TTN—dilated cardiomyopathy	0.000738	0.00473	CbGpPWpGaD
Tizanidine—ADRA2C—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000716	0.00459	CbGpPWpGaD
Tizanidine—ADRA2C—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000716	0.00459	CbGpPWpGaD
Tizanidine—ADRA2B—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000713	0.00457	CbGpPWpGaD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000711	0.00456	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000711	0.00456	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—ACTN2—dilated cardiomyopathy	0.000685	0.00439	CbGpPWpGaD
Tizanidine—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000683	0.00438	CbGpPWpGaD
Tizanidine—ADRA2C—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000666	0.00427	CbGpPWpGaD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000664	0.00426	CbGpPWpGaD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000661	0.00424	CbGpPWpGaD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00064	0.0041	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—ACTN2—dilated cardiomyopathy	0.00064	0.0041	CbGpPWpGaD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000618	0.00396	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000609	0.00391	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000609	0.00391	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TTN—dilated cardiomyopathy	0.000599	0.00384	CbGpPWpGaD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000598	0.00383	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—VCL—dilated cardiomyopathy	0.000582	0.00373	CbGpPWpGaD
Tizanidine—ADRA2A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000582	0.00373	CbGpPWpGaD
Tizanidine—ADRA2A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000582	0.00373	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000569	0.00365	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000569	0.00365	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000567	0.00363	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000549	0.00352	CbGpPWpGaD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000547	0.00351	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—VCL—dilated cardiomyopathy	0.000544	0.00349	CbGpPWpGaD
Tizanidine—ADRA2A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000541	0.00346	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00054	0.00346	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000529	0.00339	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—ACTN2—dilated cardiomyopathy	0.00052	0.00333	CbGpPWpGaD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000519	0.00333	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000513	0.00328	CbGpPWpGaD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000511	0.00327	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000502	0.00322	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000486	0.00311	CbGpPWpGaD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000485	0.00311	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000484	0.0031	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000469	0.003	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000464	0.00297	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000464	0.00297	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000462	0.00296	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000462	0.00296	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000456	0.00292	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000452	0.0029	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000445	0.00285	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000444	0.00285	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—VCL—dilated cardiomyopathy	0.000442	0.00283	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000438	0.00281	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000433	0.00278	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000433	0.00278	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000431	0.00277	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00043	0.00275	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000426	0.00273	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000423	0.00271	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ANKRD1—dilated cardiomyopathy	0.00042	0.00269	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000418	0.00268	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000416	0.00267	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000415	0.00266	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000415	0.00266	CbGpPWpGaD
Tizanidine—ADRA2B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000415	0.00266	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000403	0.00258	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000397	0.00255	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—TAZ—dilated cardiomyopathy	0.000395	0.00253	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000394	0.00252	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00039	0.0025	CbGpPWpGaD
Tizanidine—ADRA2C—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000387	0.00248	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000367	0.00235	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—SDHA—dilated cardiomyopathy	0.000357	0.00229	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000357	0.00229	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000356	0.00228	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000352	0.00226	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000352	0.00226	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000346	0.00222	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000341	0.00219	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000339	0.00217	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000337	0.00216	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000333	0.00214	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00033	0.00211	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000327	0.0021	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.000321	0.00206	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000317	0.00203	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000316	0.00203	CbGpPWpGaD
Tizanidine—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000315	0.00202	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000308	0.00197	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000305	0.00195	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000305	0.00195	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000302	0.00194	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—ITGB1—dilated cardiomyopathy	0.000292	0.00187	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.00029	0.00186	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.00029	0.00186	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.00029	0.00186	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000282	0.00181	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—ITGB1—dilated cardiomyopathy	0.000273	0.00175	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000271	0.00174	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000262	0.00168	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000262	0.00168	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000257	0.00165	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000251	0.00161	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00025	0.0016	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—CD36—dilated cardiomyopathy	0.000249	0.0016	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000245	0.00157	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000245	0.00157	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000244	0.00156	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000238	0.00153	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000238	0.00153	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000236	0.00151	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—RAC1—dilated cardiomyopathy	0.000235	0.00151	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000235	0.0015	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—CD36—dilated cardiomyopathy	0.000233	0.00149	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000229	0.00147	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000228	0.00146	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000222	0.00143	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000222	0.00143	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000222	0.00142	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000221	0.00142	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000221	0.00141	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—RAC1—dilated cardiomyopathy	0.00022	0.00141	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000214	0.00137	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000207	0.00133	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000202	0.00129	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0002	0.00128	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000199	0.00128	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000199	0.00128	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000191	0.00123	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000191	0.00122	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000189	0.00121	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000188	0.00121	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000188	0.00121	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000185	0.00119	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000183	0.00117	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000181	0.00116	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000181	0.00116	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000179	0.00115	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000179	0.00115	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000178	0.00114	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000177	0.00113	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000174	0.00111	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000171	0.0011	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000168	0.00108	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000163	0.00104	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000162	0.00104	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.00016	0.00103	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000158	0.00102	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	0.000156	0.000999	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000153	0.000981	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000149	0.000952	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000148	0.000949	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	0.000146	0.000933	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000145	0.00093	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000142	0.00091	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000141	0.000902	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000141	0.000902	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000139	0.000891	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000139	0.000889	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000135	0.000864	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000133	0.00085	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000132	0.000845	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000131	0.000842	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000131	0.000842	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000131	0.000838	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000129	0.000826	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000127	0.000812	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000126	0.000807	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000122	0.000783	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00012	0.000772	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00012	0.00077	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000118	0.000758	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.000118	0.000758	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000113	0.000722	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000108	0.000693	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000108	0.00069	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000107	0.000684	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000107	0.000684	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000103	0.000658	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000102	0.000656	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000101	0.000648	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.92e-05	0.000636	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	9.78e-05	0.000627	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.76e-05	0.000626	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	9.7e-05	0.000622	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.61e-05	0.000616	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.59e-05	0.000614	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.51e-05	0.000609	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	9.45e-05	0.000605	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.94e-05	0.000573	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.82e-05	0.000565	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.56e-05	0.000549	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	8.5e-05	0.000545	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.35e-05	0.000535	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.24e-05	0.000528	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.21e-05	0.000526	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	7.97e-05	0.000511	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	7.88e-05	0.000505	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.79e-05	0.000499	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	7.67e-05	0.000492	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	7.61e-05	0.000488	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	7.44e-05	0.000477	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	7.11e-05	0.000456	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	6.91e-05	0.000443	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.79e-05	0.000435	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.69e-05	0.000429	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.13e-05	0.000393	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.05e-05	0.000387	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	5.78e-05	0.00037	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.73e-05	0.000367	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	5.28e-05	0.000339	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	4.94e-05	0.000316	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.65e-05	0.000298	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	4.35e-05	0.000279	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	4.24e-05	0.000271	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.01e-05	0.000257	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	3.81e-05	0.000244	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	3.62e-05	0.000232	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	3.38e-05	0.000217	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.75e-05	0.000176	CbGpPWpGaD
